Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Fatos ÖNEN"'
Publikováno v:
Journal of Contemporary Medicine, Vol 12, Iss 6, Pp 846-850 (2022)
Objective: To determine the high levels of acute phase reactants (APR) of ankylosing spondylitis (AS) patients at diagnosis and follow-up, and to investigate the relationship between patients’ high levels of APR and patients’ disease activity lev
Externí odkaz:
https://doaj.org/article/651a67b08a604788b6caf4590ea8c84c
Autor:
Carla Gaggiano, Alessandra Del Bianco, Jurgen Sota, Stefano Gentileschi, Piero Ruscitti, Roberto Giacomelli, Matteo Piga, Francesca Crisafulli, Sara Monti, Giacomo Emmi, Amato De Paulis, Antonio Vitale, Maria Tarsia, Valeria Caggiano, Rossana Nuzzolese, Veronica Parretti, Claudia Fabiani, Giuseppe Lopalco, Armin Maier, Marco Cattalini, Donato Rigante, Marcello Govoni, Francesca Li Gobbi, Serena Guiducci, Paola Parronchi, Achille Marino, Francesco Ciccia, Maria Cristina Maggio, Emma Aragona, Elena Bartoloni, Annamaria Iagnocco, Ombretta Viapiana, Gian Domenico Sebastiani, Silvana Guerriero, Antonella Insalaco, Emanuela Del Giudice, Giovanni Conti, Patrizia Barone, Alma Nunzia Olivieri, Antonio Brucato, Francesco Carubbi, Paola Triggianese, Angela Mauro, Gian Marco Tosi, Alex Fonollosa, Henrique Ayres Mayrink Giardini, Gaafar Ragab, Samar Tharwat, José Hernández-Rodríguez, Petros P. Sfikakis, Katerina Laskari, Anastasios Karamanakos, Gerard Espinosa, Farhad Shahram, Haner Direskeneli, Andrea Hinojosa-Azaola, Daniela Opris-Belinski, Ibrahim A. AlMaghlouth, Gülen Hatemi, Mehmet Akif Eksin, Fatos Önen, Ewa Więsik-Szewczyk, Nurullah Akkoç, Abdurrahman Tufan, Ali Şahin, Şükran Erten, Seza Ozen, Ezgi Deniz Batu, Bruno Frediani, Alberto Balistreri, Luca Cantarini
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionThis paper describes the creation and preliminary results of a patient-driven registry for the collection of patient-reported outcomes (PROs) and patient-reported experiences (PREs) in Behçet’s disease (BD).MethodsThe project was coord
Externí odkaz:
https://doaj.org/article/0f0492e23f7f4763bef8b6d70b288317
Autor:
Zhixiu Li, Servet Akar, Handan Yarkan, Sau Kuen Lee, Pınar Çetin, Gerçek Can, Gökce Kenar, Fernur Çapa, Omer Nuri Pamuk, Yavuz Pehlivan, Katie Cremin, Erika De Guzman, Jessica Harris, Lawrie Wheeler, Ahmadreza Jamshidi, Mahdi Vojdanian, Elham Farhadi, Nooshin Ahmadzadeh, Zeynep Yüce, Ediz Dalkılıç, Dilek Solmaz, Berrin Akın, Salim Dönmez, İsmail Sarı, Paul J Leo, Tony J Kenna, Fatos Önen, Mahdi Mahmoudi, Matthew A Brown, Nurullah Akkoc
Publikováno v:
PLoS Genetics, Vol 15, Iss 4, p e1008038 (2019)
Ankylosing spondylitis (AS) is a highly heritable immune-mediated arthritis common in Turkish and Iranian populations. Familial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disease most common in people of Mediterranean origin
Externí odkaz:
https://doaj.org/article/826d7292a3574c2ba02430e31f59c49a
Publikováno v:
Journal of Contemporary Medicine. 12:846-850
Objective: To determine the high levels of acute phase reactants (APR) of ankylosing spondylitis (AS) patients at diagnosis and follow-up, and to investigate the relationship between patients’ high levels of APR and patients’ disease activity lev
Autor:
Sadettin Uslu, Semih Gulle, Gercek Sen, Ayse Cefle, Sema Yilmaz, Sinem Burcu Kocaer, Tuba Yuce Inel, Suleyman Serdar Koca, Servet Yolbas, Mehmet Akif Ozturk, Soner Senel, Nevsun Inanc, Huseyin Ediz Dalkilic, Ozgul Soysal Gunduz, Abdurrahman Tufan, Servet Akar, Ahmet Merih Birlik, Ismail Sari, Nurullah Akkoc, Fatos Onen
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Clinical data on the use of tumour necrosis factor inhibitors (TNFi) in late-onset ankylosing spondylitis (LoAS) are limited. The present study aimed to evaluate efficacy, safety, and treatment adherence associated with the initial use of TN
Externí odkaz:
https://doaj.org/article/07ea3304416b46ad8c900013a1ca1f33
Autor:
Sinakhanım Huseynzada, Tuba Yüce İnel, Farid Hajiyev, Aydan Köken Avşar, Ali Balcı, Hale Akpınar, Fatoş Önen, İsmail Sarı
Publikováno v:
European Journal of Rheumatology, Vol 10, Iss 2, Pp 50-56 (2023)
Externí odkaz:
https://doaj.org/article/f0929f2fda7242758cf38f800d9bd5fc
Autor:
Ayten Yazici, Özlem Özdemir Işık, Ediz Dalkılıç, Süleyman Serdar Koca, Yavuz Pehlivan, Soner Şenel, Nevsun Inanc, Servet Akar, Sema Yılmaz, Özgül Soysal Gündüz, Ayse Cefle, Ömer Fatih Karakaş, Fatos Onen
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract Tocilizumab (TCZ) is a recombinant humanized monoclonal antibody that targets the IL-6 receptor. TCZ found to be efficacious and has a good tolerated safety profile in rheumatoid arthritis (RA) patients. The aim of this study was to describe
Externí odkaz:
https://doaj.org/article/19120a1a963b4c70ac0f49b9a53e4fb6
Autor:
Fatoş Önen, Gerçek Can, Sedat Çapar, Ediz Dalkılıç, Yavuz Pehlivan, Soner Şenel, Servet Akar, Süleyman Serdar Koca, Abdurrahman Tufan, Ayten Yazıcı, Sema Yılmaz, Nevsun İnanç, İsmail Sarı, Merih Birlik, Dilek Solmaz, Ayşe Cefle, Mehmet Akif Öztürk, Servet Yolbaş, Niels Steen Krogh, Neslihan Yılmaz, Şükran Erten, Cemal Bes, Özgül Soysal Gündüz, Berna Göker, Seminur Haznedaroğlu, Şule Yavuz, Gözde Yildirim Çetin, Fatih Yıldız, Haner Direskeneli, Nurullah Akkoç
Publikováno v:
European Journal of Rheumatology, Vol 9, Iss 2, Pp 82-87 (2022)
Externí odkaz:
https://doaj.org/article/8f5884ed71e94008b864885d346ebf04
Autor:
Gerçek CAN, Aydan KÖKEN AVŞAR, Sinem Burcu KOCAER, Gökçe KENAR, Dilek SOLMAZ, Fatoş ÖNEN, Süleyman Serdar KOCA, Ali AKDOĞAN, Merih BİRLİK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 10, Iss 1, Pp 43-47 (2022)
Aim:Modified Rodnan Skin Score (mRSS) is generally used to assess skin involvement in patients with scleroderma. There are conflicting data on the effectiveness of mRSS training courses in previous studies. The aim of this study to evaluate the effec
Externí odkaz:
https://doaj.org/article/bad96b11d1af490d8e6eac7c942362bb
Publikováno v:
Balkan Medical Journal, Vol 36, Iss 4, Pp 251-252 (2019)
Externí odkaz:
https://doaj.org/article/c4b4c8964bbe4819a7443a2f594400c9